These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 10414233)
21. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy. Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753 [TBL] [Abstract][Full Text] [Related]
22. Splice variants of CD44 in human cervical cancer stage IB to IIB. Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775 [TBL] [Abstract][Full Text] [Related]
23. Transient expression of CD44 variant isoforms in the ontogeny of the rat: ectoderm-, endoderm- and mesoderm-derived cells express different exon combinations. Weber B; Rösel M; Arch R; Möller P; Zöller M Differentiation; 1996 Mar; 60(1):17-29. PubMed ID: 8935925 [TBL] [Abstract][Full Text] [Related]
24. CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma. Lee LN; Kuo SH; Lee YC; Chang YL; Chang HC; Jan IS; Yang PC J Formos Med Assoc; 2005 Aug; 104(8):541-8. PubMed ID: 16193174 [TBL] [Abstract][Full Text] [Related]
25. Expression of CD44 splice variants in human primary brain tumors. Kaaijk P; Troost D; Morsink F; Keehnen RM; Leenstra S; Bosch DA; Pals ST J Neurooncol; 1995 Dec; 26(3):185-90. PubMed ID: 8750184 [TBL] [Abstract][Full Text] [Related]
26. Prognostic value of CD44 variant exon 6 expression in non-small cell lung cancer: a meta-analysis. Zhao S; He JL; Qiu ZX; Chen NY; Luo Z; Chen BJ; Li WM Asian Pac J Cancer Prev; 2014; 15(16):6761-6. PubMed ID: 25169522 [TBL] [Abstract][Full Text] [Related]
27. Expression of epidermal growth factor receptor and CD44 splicing variants sharing exons 6 and 9 on gastric and esophageal carcinomas: a two-color flow-cytometric analysis. Koyama S; Maruyama T; Adachi S J Cancer Res Clin Oncol; 1999; 125(1):47-54. PubMed ID: 10037277 [TBL] [Abstract][Full Text] [Related]
28. CD44 variant expression in cutaneous T-cell lymphoma. Orteu CH; Li W; Allen MH; Smith NP; Barker JN; Whittaker SJ J Cutan Pathol; 1997 Jul; 24(6):342-9. PubMed ID: 9243361 [TBL] [Abstract][Full Text] [Related]
29. Increased expression of CD44v6 in endocrine pancreatic tumours but not in midgut carcinoid tumours. Terris B; Fléjou JF; Dubois S; Ruszniewski P; Scoazec JY; Belghiti J; Potet F; Bernades P; Mignon M; Hénin D Clin Mol Pathol; 1996 Aug; 49(4):M203-8. PubMed ID: 16696075 [TBL] [Abstract][Full Text] [Related]
30. CD44 splice variants as prognostic markers in colorectal cancer. Wielenga VJ; van der Voort R; Mulder JW; Kruyt PM; Weidema WF; Oosting J; Seldenrijk CA; van Krimpen C; Offerhaus GJ; Pals ST Scand J Gastroenterol; 1998 Jan; 33(1):82-7. PubMed ID: 9489913 [TBL] [Abstract][Full Text] [Related]
31. Expression of CD44v6 correlates with cell proliferation and cellular atypia in urothelial carcinoma cell lines 5637 and HT1197. Kuncová J; Kostrouch Z; Viale M; Revoltella R; Mandys V Folia Biol (Praha); 2005; 51(1):3-11. PubMed ID: 15783086 [TBL] [Abstract][Full Text] [Related]
32. The expression of variant exon v7-v8 CD44 antigen in relation to lymphatic metastasis of human breast cancer. Kinoshita J; Haga S; Shimizu T; Imamura H; Watanabe O; Kajiwara T Breast Cancer Res Treat; 1999 Jan; 53(2):177-83. PubMed ID: 10326795 [TBL] [Abstract][Full Text] [Related]
33. SR proteins regulate V6 exon splicing of CD44 pre-mRNA. Loh TJ; Moon H; Jang HN; Liu Y; Choi N; Shen S; Williams DR; Jung DW; Zheng X; Shen H BMB Rep; 2016 Nov; 49(11):612-616. PubMed ID: 27530682 [TBL] [Abstract][Full Text] [Related]
34. CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers. Olsson E; Honeth G; Bendahl PO; Saal LH; Gruvberger-Saal S; Ringnér M; Vallon-Christersson J; Jönsson G; Holm K; Lövgren K; Fernö M; Grabau D; Borg A; Hegardt C BMC Cancer; 2011 Sep; 11():418. PubMed ID: 21957977 [TBL] [Abstract][Full Text] [Related]
36. Expression and prognostic value of CD44 standard and variant v3 and v6 isoforms in prostate cancer. Aaltomaa S; Lipponen P; Ala-Opas M; Kosma VM Eur Urol; 2001 Feb; 39(2):138-44. PubMed ID: 11223672 [TBL] [Abstract][Full Text] [Related]
37. Splice variants of the cell surface glycoprotein CD44 associated with metastatic tumour cells are expressed in normal tissues of humans and cynomolgus monkeys. Heider KH; Mulder JW; Ostermann E; Susani S; Patzelt E; Pals ST; Adolf GR Eur J Cancer; 1995 Dec; 31A(13-14):2385-91. PubMed ID: 8652273 [TBL] [Abstract][Full Text] [Related]
38. Differential expression of CD44 splice variants in malignant and benign pleural effusions. Tojo N; Inase N; Ichioka M; Miyazato I; Nara N Tohoku J Exp Med; 1996 Aug; 179(4):273-9. PubMed ID: 8944429 [TBL] [Abstract][Full Text] [Related]
39. The prognostic value of CD44 isoform expression in endometrial cancer. Tempfer C; Haeusler G; Kaider A; Hefler L; Hanzal E; Reinthaller A; Breitenecker G; Kainz C Br J Cancer; 1998 Apr; 77(7):1137-9. PubMed ID: 9569051 [TBL] [Abstract][Full Text] [Related]
40. CD44 exon v6 is not implicated in the progression and metastasis of endometrial cancer. Tokumo K; Kodama J; Seki N; Miyagi Y; Yoshinouchi M; Kudo T Cancer Lett; 1998 Mar; 125(1-2):221-5. PubMed ID: 9566719 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]